Conduce Health Raises $3M in Seed Funding

In the dynamic world of healthcare technology, Conduce Health has recently achieved a significant milestone by securing a successful seed funding round. AlphaFund, known for partnering with venture capital firms across North America and interviewing founders from various industries, sat down with Eric Rosow of Conduce Health. In this exclusive interview, we explore the intricacies of their seed funding success, the company’s objectives, and the future that lies ahead.

Interview with Eric Rosow of Conduce Health

Q1: Can you introduce Conduce Health and share what led to the successful closure of your seed funding round?
A1: Conduce Health is a NYC-based healthcare technology company at the fore of value-based care. Our journey has been about developing a holistic solution that revolutionizes how primary care and specialists interact. The successful closure of our seed funding round has been a product of our innovative platforms, results, and the untapped potential in our market.

Q2: Congratulations on raising $3M in your seed round. How does this financial milestone align with your company’s goals?
A2: Thank you. This crucial funding will help us extend our operations and significantly enlarge our business reach. Our goal is to make our single platform for managing specialty care risk widely accessible, thus raising the bar for healthcare provision.

Q3: Who were the key investors or venture capital firms in this seed round, and what drove them to invest in Conduce Health?
A3: We were fortunate to have key investors including Connecticut Innovations, AlleyCorp, CityLight, and others. Their investment was driven by our progressive model, excellent performance, and a unique approach in a rapidly growing industry.

Q4: Operating within the healthcare technology sector, how does Conduce Health aim to impact this sector?
A4: Conduce Health aims to revolutionize multi-specialty value-based care. We streamline contracting and payment processes, and use data science to match patients with the right specialists. We strive to simplify and refine patient care.

Q5: With the seed funding secured, what are the main objectives or plans for utilizing this capital?
A5: The new funds will be channeled to expand our operations. We also intend to increase the number of specialists on our platform, expand our presence in the Southeast, and invest in new technologies to improve our services.

Q6: Could you share some significant milestones or achievements of Conduce Health that were pivotal in securing this seed funding?
A6: Launching our live marketplace supporting patient care in South Carolina and Georgia and attaining a network of over 150 specialty physicians were key achievements. These demonstrated a proof of concept and established us as serious players in the health-tech industry.

Q7: How will the seed round influence Conduce Health’s future plans and growth strategy? Are there any upcoming projects or directions that are now possible because of this funding?
A7: The seed funding helps us expedite our plans. Notably, we aim to significantly expand throughout the Southeast. Also, it enables us to flesh out exciting projects to enhance our platform with more forward-thinking technologies.

Conclusion:
Through this insightful conversation with Eric Rosow, it’s clear that Conduce Health is on a trajectory of growth and innovation, fueled by their recent seed funding. AlphaFund, with its extensive network of VC partnerships across North America, continues to spotlight the journeys of companies like Conduce Health, showcasing the vibrant landscape of opportunities and entrepreneurial spirit across multiple industries.

Stay in the Loop

Join our mailing list to stay in the loop to stay informed, for free.

Latest stories

You might also like...